Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 16 studies | 40% ± 10% |
Insufficient scRNA-seq data for expression of DNAI3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 88% | 77.86 | 1589 / 1809 | 66% | 7.68 | 310 / 472 |
thymus | 93% | 62.41 | 608 / 653 | 47% | 0.97 | 286 / 605 |
adrenal gland | 100% | 1693.74 | 258 / 258 | 37% | 3.94 | 85 / 230 |
kidney | 97% | 59.84 | 86 / 89 | 30% | 0.65 | 266 / 901 |
lung | 94% | 205.41 | 541 / 578 | 23% | 0.83 | 260 / 1155 |
uterus | 49% | 55.34 | 84 / 170 | 22% | 0.76 | 103 / 459 |
breast | 46% | 15.40 | 211 / 459 | 21% | 0.51 | 237 / 1118 |
heart | 64% | 48.34 | 548 / 861 | 0% | 0 | 0 / 0 |
brain | 39% | 71.55 | 1038 / 2642 | 23% | 1.08 | 159 / 705 |
eye | 0% | 0 | 0 / 0 | 55% | 1.23 | 44 / 80 |
prostate | 45% | 18.78 | 111 / 245 | 6% | 0.17 | 32 / 502 |
ovary | 12% | 3.94 | 22 / 180 | 27% | 0.94 | 115 / 430 |
esophagus | 28% | 9.04 | 410 / 1445 | 3% | 0.07 | 5 / 183 |
spleen | 31% | 8.95 | 74 / 241 | 0% | 0 | 0 / 0 |
adipose | 26% | 7.74 | 310 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 25% | 31.35 | 235 / 929 | 0% | 0 | 0 / 0 |
intestine | 21% | 5.63 | 204 / 966 | 3% | 0.08 | 18 / 527 |
bladder | 10% | 2.00 | 2 / 21 | 8% | 0.17 | 40 / 504 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.37 | 5 / 29 |
stomach | 13% | 3.15 | 45 / 359 | 3% | 0.04 | 8 / 286 |
blood vessel | 14% | 4.04 | 185 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.16 | 6 / 45 |
pancreas | 5% | 1.35 | 16 / 328 | 8% | 0.25 | 15 / 178 |
muscle | 4% | 1.30 | 36 / 803 | 0% | 0 | 0 / 0 |
liver | 0% | 0.20 | 1 / 226 | 2% | 0.04 | 8 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0034316 | Biological process | negative regulation of Arp2/3 complex-mediated actin nucleation |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0060294 | Biological process | cilium movement involved in cell motility |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0036159 | Biological process | inner dynein arm assembly |
GO_0036156 | Cellular component | inner dynein arm |
GO_0005858 | Cellular component | axonemal dynein complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0045503 | Molecular function | dynein light chain binding |
GO_0005515 | Molecular function | protein binding |
GO_0071933 | Molecular function | Arp2/3 complex binding |
GO_0045504 | Molecular function | dynein heavy chain binding |
Gene name | DNAI3 |
Protein name | Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63) Alternative protein WDR63 Dynein axonemal intermediate chain 3 |
Synonyms | WDR63 |
Description | FUNCTION: Acts as a negative regulator of cell migration, invasion, and metastasis downstream of p53/TP53, through inhibition of Arp2/3 complex-mediated actin polymerization . Via its association with the multisubunit axonemal dynein complex, is potentially involved in the regulation of cilia function (By similarity). May play a role in osteogenesis of dental tissue-derived mesenchymal stem cells (By similarity). . |
Accessions | ENST00000294664.11 [Q8IWG1-1] E9PLW4 ENST00000464801.1 Q8IWG1 H0YEC9 ENST00000528899.5 ENST00000484007.1 L8E9L7 ENST00000326813.12 [Q8IWG1-2] E9PLK2 ENST00000370596.5 [Q8IWG1-2] |